RxDoctor Payments Data

Andrew Windsperger, MD

Urology · Sartell, MNNPI 1124280425

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $17,951 of the $23,658 with a category attached, or 75.9%. SWAN Valley Medical Incorporated accounts for 74.5% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2022 at $14,091 and has fallen 71.6% since, to $4,002 in 2025. Among urology clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$23,658in general payments, 2019–2025

Across 39 payments — averaging $606.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • SWAN Valley Medical Incorporated$18K
  • Uromedica, Incorporated$3K
  • Medtronic$2K
  • Arthrex$1K
  • Boston Scientific$82
  • C. R. Bard, Inc. & Subsidiaries$79
  • plus $291 from 11 others
$204,219in research payments, 2019–2025

Across 58 payments — averaging $3521.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Urovant Sciences Inc$97K
  • Sumitomo Pharma America, Inc.$94K
  • Uromedica, Incorporated$10K
  • Medtronic$2K
$0in ownership & investment interests, 2019–2025

Across 3 payments — averaging $0.00 each. An ownership or investment interest held by the physician or an immediate family member.

  • SWAN Valley Medical Incorporated$0

What the payments were for

  • Consulting fees$17,95176%
  • Speaking & faculty fees$2,51511%
  • Travel & lodging$1,1345%
  • Food & beverage$8043%
  • Education$1,2545%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,658 in reported general payments places this provider in the 90th percentile of 247 urology providers in Minnesota.

See all urology providers in Minnesota

Medicare billing

Part B allowed, 2024
$172,394
Medicare patients
488
Services billed
9,070

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron389$315,408
GemtesaVibegron46$50,751
ElmironPentosan Polysulfate Sodium26$25,782
Tamsulosin Hcl614$13,736
Solifenacin Succinate245$11,679
Mirabegron ErMirabegron16$11,621
Oxybutynin Chloride ErOxybutynin Chloride250$8,741
Fosfomycin Tromethamine17$8,146
Fesoterodine Fumarate ErFesoterodine Fumarate63$6,186
Dutasteride166$5,156
Trospium Chloride ErTrospium Chloride22$4,905
Methenamine Hippurate68$4,846
Trospium Chloride91$3,605
Tolterodine Tartrate ErTolterodine Tartrate51$3,599
Estradiol49$3,535

Paid to pharmacies, not to this prescriber.

Other urology in Sartell

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →